{"id":1156,"text":"Current address: Drug Metabolism and Pharmacokinetics, Covance Laboratories Inc., Madison, WI, USA Patients commonly take complementary medicines in conjunction with warfarin yet evidence supporting the safety or the risk of a herb–drug interaction is lacking.","label":[[166,174,"Drug"]],"Comments":[]}
{"id":1157,"text":"The aim of this study was to investigate the possible impact of two commonly used herbal medicines, garlic and cranberry, on the pharmacokinetics and pharmacodynamics of warfarin in healthy male subjects.","label":[[100,106,"Herb name"],[111,120,"Herb name"],[170,178,"Drug"],[182,189,"Pathology"],[190,194,"Sex"]],"Comments":[]}
{"id":1158,"text":"An open-label, three-treatment, randomized crossover clinical trial was undertaken and involved 12 healthy male subjects of known CYP2C9 and VKORC1 genotype.","label":[[0,67,"Study"],[96,120,"Cohort"],[99,106,"Pathology"],[130,156,"Parameter"]],"Comments":[]}
{"id":1159,"text":"A single dose of 25 mg warfarin was administered alone or after 2 weeks of pretreatment with either garlic or cranberry.","label":[[0,13,"Frequency"],[17,22,"Amount"],[23,31,"Drug"],[57,71,"Duration"],[100,106,"Herb name"],[110,119,"Herb name"]],"Comments":[]}
{"id":1160,"text":"Warfarin enantiomer concentrations, INR, platelet aggregation and clotting factor activity were measured to assess pharmacokinetic and pharmacodynamic interactions between warfarin and herbal medicines.","label":[[0,8,"Drug"],[0,34,"Parameter"],[36,39,"Parameter"],[41,61,"Parameter"],[66,90,"Parameter"],[172,180,"Drug"]],"Comments":[]}
{"id":1161,"text":"Cranberry significantly increased the area under the INR–time curve by 30% when administered with warfarin compared with treatment with warfarin alone.","label":[[0,9,"Herb name"],[34,67,"Parameter"],[71,74,"Amount"],[98,106,"Drug"],[136,144,"Drug"]],"Comments":[]}
{"id":1162,"text":"Cranberry did not alter S- or R-warfarin pharmacokinetics or plasma protein binding.","label":[[0,9,"Herb name"],[24,40,"Drug"],[61,83,"Parameter"]],"Comments":[]}
{"id":1163,"text":"Co-administration of garlic did not significantly alter warfarin pharmacokinetics or pharmacodynamics.","label":[[21,27,"Herb name"],[56,64,"Drug"],[56,101,"Parameter"]],"Comments":[]}
{"id":1164,"text":"Both herbal medicines showed some evidence of VKORC1 (not CYP2C9) genotype-dependent interactions with warfarin, which is worthy of further investigation.","label":[[46,52,"Parameter"],[58,64,"Parameter"],[103,111,"Drug"]],"Comments":[]}
{"id":1165,"text":"Cranberry alters the pharmacodynamics of warfarin with the potential to increase its effects significantly.","label":[[0,9,"Herb name"],[41,49,"Drug"]],"Comments":[]}
{"id":1166,"text":"Co-administration of warfarin and cranberry requires careful monitoring.","label":[[21,29,"Drug"],[34,43,"Herb name"]],"Comments":[]}
{"id":1167,"text":"International normalized ratio of prothrombin time (INR) vs time profile (n=12) after a single oral dose of warfarin (25 mg) alone, and after multiple dose of cranberry juice concentrate capsules and after multiple dose of enteric-coated garlic tablets.","label":[[0,56,"Parameter"],[88,104,"Frequency"],[108,116,"Drug"],[118,123,"Amount"],[142,155,"Frequency"],[159,168,"Herb name"],[159,186,"Extraction process"],[206,219,"Frequency"],[223,252,"Extraction process"],[238,244,"Herb name"]],"Comments":[]}
{"id":1168,"text":"Individual area under the international normalized ratio (INR)–time curve (AUC Percentage clotting activity vs midpoint time profiles for (a) Factor II, (b) Factor VII and (c) Factor X during warfarin treatment alone or after cranberry pretreatment.","label":[[0,78,"Parameter"],[90,107,"Parameter"],[142,151,"Parameter"],[157,167,"Parameter"],[176,184,"Parameter"],[192,200,"Drug"],[226,235,"Herb name"]],"Comments":[]}
{"id":1169,"text":"Mean and s.d.","label":[],"Comments":[]}
{"id":1170,"text":"(error bars) are presented.","label":[],"Comments":[]}
{"id":1171,"text":"Plasma concentration–time profile of (a) S-warfarin and (b) R-warfarin after a single oral dose of warfarin (25 mg) alone, or after multiple doses of cranberry juice concentrate capsules given along with single dose of warfarin and after multiple doses of enteric-coated garlic tablets.","label":[[0,70,"Parameter"],[41,51,"Drug"],[60,70,"Drug"],[79,95,"Frequency"],[99,107,"Drug"],[109,114,"Amount"],[132,146,"Frequency"],[150,159,"Herb name"],[150,186,"Extraction process"],[204,215,"Frequency"],[219,227,"Drug"],[238,252,"Frequency"],[256,285,"Extraction process"],[271,277,"Herb name"]],"Comments":[]}
{"id":1172,"text":"Warfarin pharmacodynamic end points following the different treatments Abbreviations: CI, confidence interval; INR, international normalized ratio of prothrombin time; INR Pharmacokinetic parameters of S-warfarin and R-warfarin Abbreviations: AUC, area under the plasma concentration–time curve; CI, confidence interval; CL, clearance; CL\/F, apparent clearance; C Population pharmacokinetic and pharmacodynamic parameter estimates derived from the combined data from all treatment arms Abbreviations: CL, clearance; CL\/F, apparent clearance; CV, coefficient of variation; EC The impact of herbal medicine treatment was evaluated as a ratio of the treatment to control on specific parameters (e.g., EC Geometric mean ratio intervention to control.","label":[[0,8,"Drug"],[111,166,"Parameter"],[168,171,"Parameter"],[202,212,"Drug"],[217,227,"Drug"],[243,294,"Parameter"],[296,319,"Parameter"],[321,334,"Parameter"],[336,360,"Parameter"],[501,514,"Parameter"],[516,540,"Parameter"]],"Comments":[]}
{"id":1173,"text":"EC Abbreviations: CI, confidence interval; VKORC1, vitamin K epoxide reductase subunit 1.","label":[[43,88,"Parameter"]],"Comments":[]}
{"id":1174,"text":"S-warfarin apparent clearance (mL h Abbreviations: CI, confidence interval; CYP2C9, cytochrome P450 2C9 gene.","label":[[0,10,"Drug"],[11,35,"Parameter"],[76,108,"Parameter"]],"Comments":[]}
